[HTML] nature.comFull View

[HTML][HTML] The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1

B Zhang, D Fu, Q Xu, X Cong, C Wu, X Zhong… - Nature …, 2018 - nature.com
The senescence-associated secretory phenotype (SASP) can be provoked by side effects of
therapeutic agents, fueling advanced complications including cancer resistance. However …
被引用次数：119 相关文章

The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1.

B Zhang, D Fu, Q Xu, X Cong, C Wu, X Zhong… - Nature …, 2018 - europepmc.org
The senescence-associated secretory phenotype (SASP) can be provoked by side effects of
therapeutic agents, fueling advanced complications including cancer resistance. However …

The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1.

B Zhang, D Fu, Q Xu, X Cong, C Wu… - Nature …, 2018 - search.ebscohost.com
The senescence-associated secretory phenotype (SASP) can be provoked by side effects of
therapeutic agents, fueling advanced complications including cancer resistance. However …

The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1

B Zhang, D Fu, Q Xu, X Cong, C Wu… - Nature …, 2018 - pubmed.ncbi.nlm.nih.gov
The senescence-associated secretory phenotype (SASP) can be provoked by side effects of
therapeutic agents, fueling advanced complications including cancer resistance. However …

The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1

B Zhang, D Fu, Q Xu, X Cong, C Wu… - Nature …, 2018 - ui.adsabs.harvard.edu
The senescence-associated secretory phenotype (SASP) can be provoked by side effects of
therapeutic agents, fueling advanced complications including cancer resistance. However …

The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1

B Zhang, D Fu, Q Xu, X Cong, C Wu, X Zhong… - Nature …, 2018 - ideas.repec.org
The senescence-associated secretory phenotype (SASP) can be provoked by side effects of
therapeutic agents, fueling advanced complications including cancer resistance. However …

The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1

B Zhang, D Fu, Q Xu, X Cong, C Wu… - Nature …, 2018 - econpapers.repec.org
The senescence-associated secretory phenotype (SASP) can be provoked by side effects of
therapeutic agents, fueling advanced complications including cancer resistance. However …

The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1

B Zhang, D Fu, Q Xu, X Cong… - Nature …, 2018 - mdanderson.elsevierpure.com
The senescence-associated secretory phenotype (SASP) can be provoked by side effects of
therapeutic agents, fueling advanced complications including cancer resistance. However …

The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1

B Zhang, QX Da Fu, X Cong, C Wu, X Zhong… - Nature …, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The senescence-associated secretory
phenotype (SASP) can be provoked by side effects of therapeutic agents, fueling advanced …
[HTML] nih.gov

[HTML][HTML] The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1

B Zhang, D Fu, Q Xu, X Cong, C Wu… - Nature …, 2018 - ncbi.nlm.nih.gov
The senescence-associated secretory phenotype (SASP) can be provoked by side effects of
therapeutic agents, fueling advanced complications including cancer resistance. However …